| The poly (ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial SK Sandhu, WR Schelman, G Wilding, V Moreno, RD Baird, S Miranda, ... The lancet oncology 14 (9), 882-892, 2013 | 626 | 2013 |
| Phase I dose-escalation study of JNJ-42756493, an oral pan–fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors J Tabernero, R Bahleda, R Dienstmann, JR Infante, A Mita, A Italiano, ... Journal of clinical oncology 33 (30), 3401-3408, 2015 | 406 | 2015 |
| First-in-human phase I study of pictilisib (GDC-0941), a potent pan–class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors D Sarker, JE Ang, R Baird, R Kristeleit, K Shah, V Moreno, PA Clarke, ... Clinical cancer research 21 (1), 77-86, 2015 | 334 | 2015 |
| KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ... PloS one 4 (12), e8199, 2009 | 197 | 2009 |
| Phase Ia and Ib studies of the novel carcinoembryonic antigen (CEA) T-cell bispecific (CEA CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary … J Tabernero, I Melero, W Ros, G Argiles, A Marabelle, ME Rodriguez-Ruiz, ... Journal of Clinical Oncology 35 (15_suppl), 3002-3002, 2017 | 173 | 2017 |
| PL02. 08 registrational results of LIBRETTO-001: a phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancers A Drilon, G Oxnard, L Wirth, B Besse, O Gautschi, SWD Tan, H Loong, ... Journal of Thoracic Oncology 14 (10), S6-S7, 2019 | 106 | 2019 |
| Combining antiangiogenics to overcome resistance: rationale and clinical experience V Moreno Garcia, B Basu, LR Molife, SB Kaye Clinical Cancer Research 18 (14), 3750-3761, 2012 | 83 | 2012 |
| Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy V Moreno García, P Cejas, M Blanco Codesido, J Feliu Batlle, ... International journal of colorectal disease 24, 741-748, 2009 | 69 | 2009 |
| Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target E Casado, VM Garcia, JJ Sánchez, MTG Del Pulgar, J Feliu, J Maurel, ... International Journal of Radiation Oncology* Biology* Physics 84 (5), 1151-1158, 2012 | 29 | 2012 |
| Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy VM García, JF Batlle, E Casado, E Burgos, J de Castro, C Belda, ... Colorectal Disease 13 (9), 989-998, 2011 | 27 | 2011 |
| Parallel anticancer drug development and molecular stratification to qualify predictive biomarkers: dealing with obstacles hindering progress VM Garcia, PA Cassier, J de Bono Cancer Discovery 1 (3), 207-212, 2011 | 26 | 2011 |
| Dose–response relationship in phase I clinical trials: a European Drug Development Network (EDDN) collaboration study V Moreno García, D Olmos, C Gomez-Roca, PA Cassier, ... Clinical cancer research 20 (22), 5663-5671, 2014 | 22 | 2014 |
| Altered VDR-mediated transcriptional activity in prostate cancer stroma AA Hidalgo, R Paredes, VM Garcia, G Flynn, CS Johnson, DL Trump, ... The Journal of steroid biochemistry and molecular biology 103 (3-5), 731-736, 2007 | 17 | 2007 |
| Association of creatine kinase and skin toxicity in phase I trials of anticancer agents V Moreno Garcia, P Thavasu, M Blanco Codesido, LR Molife, ... British journal of cancer 107 (11), 1797-1800, 2012 | 15 | 2012 |
| Differentiating the amending effects of calcareous materials applied to acid soils by use of optimal scaling procedures. M Vidal, E Garzon, V Garcia, E Villa | 15 | 2006 |
| Dissipation of 14c‐p,p'‐DDT in two Panamanian soils J Espinosa‐González, V Garcia, J Ceballos Journal of Environmental Science & Health Part B 29 (1), 97-102, 1994 | 6 | 1994 |
| Outcomes of patients with metastatic melanoma treated with molecularly targeted agents in phase I clinical trials M Blanco Codesido, A Tesainer Brunetto, S Frentzas, V Moreno Garcia, ... Oncology 81 (2), 135-140, 2011 | 5 | 2011 |
| 1248 POSTER A Phase I Study Evaluating GDC-0941, a Pan-phosphoinositide-3 Kinase (PI3K) Inhibitor, in Patients (pts) With Advanced Solid Tumours, Multiple Myeloma, and PIK3Ca … S Banerjee, R Baird, B Basu, K Shah, N Tunariu, VM Garcia, J Corral, ... European Journal of Cancer, S159, 2011 | 3 | 2011 |
| Models for predicting composition and temporal structure of chemical parameters for leachates from amended acid soils M Vidal, E Garzon, V Garcia, A Ontanon, E Villa Communications in soil science and plant analysis 35 (11-12), 1517-1542, 2004 | 3 | 2004 |
| Aplicación de dos enmiendas calizas en suelos ácidos dedicados al cultivo de la variedad Mencía MA Olego, JE Garzón, JJ Rubio, VM García, JM Álvarez, MJ Quiroga Vida Rural 347, 52-59, 2012 | 2 | 2012 |
